Predilife presents MammoRisk®
The first breast cancer risk prediction solution in France
Since 2019, Predilife has been marketing MammoRisk®, the first breast cancer risk prediction solution in France offering women a clear report for personalised screening..
The MammoRisk® test integrates the latest scientific knowledge in terms of risk factors (clinical data, imaging and medical biology) in order to provide to each woman a unique and adapted monitoring.
Today, all women from 40 years of age can request a risk consultation from their doctor and have their breast cancer risk assessment.